These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 16844690

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Molecular organization of C9 within the membrane attack complex of complement. Induction of circular C9 polymerization by the C5b-8 assembly.
    Podack ER, Tschoop J, Müller-Eberhard HJ.
    J Exp Med; 1982 Jul 01; 156(1):268-82. PubMed ID: 6177822
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Homologous restriction factor: effect on complement C8 and C9 uptake and lysis.
    Zalman LS, Müller-Eberhard H.
    Mol Immunol; 1994 Mar 01; 31(4):301-5. PubMed ID: 8139583
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers.
    Meri S, Morgan BP, Davies A, Daniels RH, Olavesen MG, Waldmann H, Lachmann PJ.
    Immunology; 1990 Sep 01; 71(1):1-9. PubMed ID: 1698710
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Interaction between the C8 alpha-gamma and C8 beta subunits of human complement C8: role of the C8 beta N-terminal thrombospondin type 1 module and membrane attack complex/perforin domain.
    Musingarimi P, Plumb ME, Sodetz JM.
    Biochemistry; 2002 Sep 17; 41(37):11255-60. PubMed ID: 12220191
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Proteoform Profile Mapping of the Human Serum Complement Component C9 Revealing Unexpected New Features of N-, O-, and C-Glycosylation.
    Franc V, Yang Y, Heck AJ.
    Anal Chem; 2017 Mar 21; 89(6):3483-3491. PubMed ID: 28221766
    [Abstract] [Full Text] [Related]

  • 57. H19, a surface membrane molecule involved in T-cell activation, inhibits channel formation by human complement.
    Whitlow MB, Iida K, Stefanova I, Bernard A, Nussenzweig V.
    Cell Immunol; 1990 Mar 21; 126(1):176-84. PubMed ID: 1689219
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Relative Contribution of Cellular Complement Inhibitors CD59, CD46, and CD55 to Parainfluenza Virus 5 Inhibition of Complement-Mediated Neutralization.
    Li Y, Parks GD.
    Viruses; 2018 Apr 25; 10(5):. PubMed ID: 29693588
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.